Skip to main content

Health and Medicine

VU, Lipscomb partner on dual degree program

Aug. 23, 2012—A new cooperative program between Vanderbilt University and Lipscomb University’s College of Pharmacy is focusing on the next generation of pharmaceutical researchers. By offering a pathway for students to earn both Pharm.D. and Ph.D. degrees, the program aims to boost the number of pharmacy-trained research scientists.

Read more


Gene linked to familial prostate cancer

Aug. 23, 2012—A rare, inherited mutation confers an eightfold increased risk of prostate cancer, a recent study shows.

Read more


Method may refine personalized trials for cancer therapy

Aug. 16, 2012—A new tool to observe cell behavior has revealed surprising clues about how cancer cells respond to therapy, and may offer a way to further refine personalized cancer treatments.

Read more


African ancestry, stomach bug link

Aug. 16, 2012—Socioeconomic factors, African ancestry linked to risk for cancer-causing infection.

Read more


Flu Tool guides patient decision-making

Aug. 14, 2012—Studies of Flu Tool, a computer application that guides health care decision-making, suggests that patients are willing to use these types of resources.

Read more


Key to a woman’s heart (condition)?

Aug. 10, 2012—Females may be at higher risk of potentially fatal heart condition due to gender differences in a protein involved in the heart’s electrical activity.

Read more


New therapeutic target for cold, flu viruses identified

Aug. 9, 2012—Viruses that cause acute respiratory infections — such as human metapneumovirus (HMPV) and flu — impair a set of immune system cells that should clear the virus from the lungs. Now, Vanderbilt University investigators have discovered the signaling pathway that disables these immune cells.

Read more


Study links rare genetic marker to brain cancer

Aug. 9, 2012—Investigators from Vanderbilt-Ingram Cancer Center and three other cancer centers have identified a link between a rare genetic variant and the risk of developing glioma.

Read more


Team creates new view of body’s infection response

Aug. 9, 2012—A new 3-D view of the body’s response to infection — and the ability to identify proteins involved in the response — could point to novel biomarkers and therapeutic agents for infectious diseases.

Read more


Network approach yields glioblastoma clues

Aug. 9, 2012—MicroRNA “regulatory networks” generated at Vanderbilt aid search for biomarkers and new drugs to treat glioblastoma, the most common and lethal primary brain tumor.

Read more


Ancestry impacts smoking risk for lungs

Aug. 7, 2012—Smoking is more detrimental to lung function in individuals with high proportions of African ancestry.

Read more


Early HIV treatment also can prevent TB: study

Aug. 2, 2012—Anti-retroviral therapy can prevent tuberculosis, even in people with early HIV disease.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more